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Abstract
Wilson’s disease, characterized by cirrhosis, extrapyramidal symp-
toms and Kayser-Fleischer corneal rings, is a rare hereditary dis-
ease of human copper metabolism. Clinical findings in Wilson’s 
disease are complex and neurological symptoms such as tremor, 
dysarthria,  rigid  dystonia,  seizures,  psychiatric  disorders,  acute 
liver failure, chronic hepatitis or cirrhosis may develop. A 4-year-
old male patient was operated for traumatic depressed skull frac-
ture and intracerebral hematoma. He was diagnosed with Wilson’s 
disease at the age of 2.5 years and treated with zinc sulphate and 
D-penicillamine. General anesthesia was induced with propofol, 
fentanyl, atracurium, and maintained with isoflurane, and oxygen. 
No complications were encountered during the operation or in the 
postoperative  period. We  concluded  that  general  anesthesia  can 
successfully be given to Wilson’s disease patients using an anes-
thetic agent, the metabolism of which is least affected by the liver 
disease, one that induces least hepatic toxicity. By close follow-up 
of patients clinically and biochemically, it is possible to reduce the 
complication rates to a minimum.
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Introduction
Wilson’s  disease  (WD),  also  known  as  hepatolenticular 
degeneration, is an autosomal recessive disorder character-
ized by a reduction in the synthesis of the copper transporter 
protein ceruloplasmin [1]. WD involves loss of the ability 
to export copper from the liver into bile and to incorporate 
copper into hepatic ceruloplasmin. Accumulation of copper 
in various organs and tissues occurs, especially in the liver, 
brain, kidneys, and cornea [2]. It can present clinically as liv-
er disease, as a progressive neurological disorder, or as psy-
chiatric illness. WD presents with liver disease more often in 
children and younger adult patients than in older adults. The 
type of the liver disease can be highly variable, ranging from 
asymptomatic with only biochemical abnormalities to acute 
liver failure or chronic liver disease leading to cirrhosis [3]. 
Due to this existing liver disease, anesthetic management 
presents a challenge in WD cases in terms of anesthetic tech-
nique and anesthetic drugs to be used. With this case report, 
we are discussing our anesthesia protocol we used during an 
emergency surgical procedure for trauma in a pediatric WD 
patient and experiences in perioperative and postoperative 
periods.
 
Case Report
A 4-year old male patient with normal motor and mental 
development was brought to the emergency room where he 
was assessed, after falling from height. During the physical 
examination,  hematoma  of  the  right  upper  eyelid,  swell-
ing of the right half of the frontal region, and ecchymosis 
measuring 5 x 4 cm over infero-lateral aspect of the right 
hemithorax were noted. Patient was responsive, cooperated 
but  somnolent.  Cranial  computed  tomography  revealed  a 
depressed fracture of the right half of the frontal bone and 
hematoma measuring 2 x 3 cm on the lateral aspect of the 
right frontal lobe. Chest roentgenogram and thoracic com-
puted tomography showed increased parenchymal density in 
the right paracardiac area and irregular, nodular infiltration 
in the right lower lobe, respectively. Family history revealed 
that patient’s parents were related, that three of his siblings 
(2 brothers and 1 sister) had WD and that one brother and 
one sister died of liver failure. Patient has been followed-up 
since the age of 9 months and had liver biopsy 18 months 
earlier that showed minimal hepatitis. Patient did not have 
Kaiser-Fleischer ring and Stage I WD was diagnosed when 
serum alanine aminotransferase (ALT): 48 IU/L, the serum 
aspartate aminotransferase (AST): 47 IU/L, ceruloplasmin: 
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2.26 mg/dL, 24-hour urinary copper excretion: 370 µg. Pa-
tient was placed on zinc sulphate 45 mg/day and D-penicilla-
mine 750 mg/day and this treatment was maintained without 
any interruptions. Preoperative tests showed Hemoglobin: 
10.2 g/dL, Platelets: 272,000 /mm3, Na: 140 mmol/L, K: 3.8 
mmol/L, BUN: 8 mg/dL, Creatine: 0.5 mg/dL, International 
normalized ratio (INR): 1.16, ALT: 24 IU/L, AST: 38 IU/L. 
General anesthesia was induced with intravenous 2 mg/
kg propofol, 2 µg/kg fentanyl, 0.5 mg/kg atracurium, and 
maintained with 0.8 - 1.5% isoflurane, in 50% air and 50% 
oxygen. ET CO2 was maintained between 28 - 34 mm Hg. 
During the operation, drainage of the hematoma and duro-
plasty were performed. Patient was stable hemodynamically 
throughout the surgery, extubated without any problems and 
taken to the intensive care unit. He was fully alert and re-
sponsive in postoperative 3 hours. There was no postopera-
tive deterioration in the liver or renal functions. All of the 
routine laboratory tests were within the normal limits. Zinc 
sulphate and D-penicillamine treatment at pre-operation dos-
es was restarted at postoperative 12 hours. No pathology was 
noted on chest roentgenogram taken on day 3. The patient 
was discharged after recovery on the day 7 of the surgery. 
Clinical examination and laboratory tests did not show any 
pathology during follow-up visit at 1 month. 
Discussion
  
Although WD is congenital, signs and symptoms first appear 
around the age of 6 years. First sign in the majority of cases, 
especially in children, is liver disease. When there is a posi-
tive family history and parents are related to each other, the 
risk among offspring of being affected is 25%. All siblings 
of our patient had undergone family screening in their first 
year of life due to history of WD. The patient who was as-
ymptomatic was diagnosed early with WD when fine needle 
aspiration biopsy from the liver showed histological features 
of  autoimmune  hepatitis,  serum  ceruloplasmin  level  was 
low and 24-hour urinary copper excretion was significant-
ly above its basal level. The patient was placed on medical 
treatment, aiming to prevent the progression of the disease 
and, consequently, severe sequels and organ damage in the 
long term and to lead a normal life.  
Decrease in total hepatic blood flow which occurs nor-
mally during general anesthesia, the effects of anesthetics 
that are toxic to the liver, decreased blood pressure during 
anesthesia and decrease in tissue perfusion as a result of 
surgery may further disrupt hepatic function that is already 
impaired in WD and cause hepatic injury. On the other hand, 
impaired hepatic function can adversely affect the absorp-
tion, distribution, metabolism, and excretion of anesthetics, 
muscle relaxants, analgesics and sedatives. In fact, there is 
no optimal anesthetic drug in chronic liver diseases such as 
WD. Still, phentanyl, a narcotic agent that is least affected 
by these and isoflurane, an inhaled anesthetic that increases 
hepatic blood flow are safer choices [4]. 
Further, there is an increase in sensitivity to neuromus-
cular relaxants in WD patients. This is related to decreased 
muscle function due to the disease itself and D-penicillamine 
use over the years.  
Therefore, the effect of neuromuscular blocking agents 
may be prolonged in patients with WD. Atracurium, which 
we used, is considered as first choice because it relies on 
neither the liver nor kidney for excretion.  
A case of WD diagnosed by occurrence of acute neu-
ropsychiatric symptoms after general anesthesia has been 
reported [5]. Hypnotic and sedative drugs interfere signifi-
cantly with the central nervous system and may, therefore, 
exacerbate  neurological  and  psychiatric  problems  in  the 
postoperative period [1]. Moreover, in addition to the ad-
verse effects of general anesthesia on the central nervous 
system, those related to concomitance of head trauma and 
neurosurgery  can  cause  occurrence  of  neuropsychiatric 
symptoms. However, there was no known preoperative neu-
ropsychiatric symptom in our patient and it was not observed 
postoperatively.  
Due to their potential to trigger liver disease and cause 
conditions specific to WD such as hemolytic anemia, serum 
aminotransferases, INR and hemoglobin were closely moni-
tored in the postoperative period and no pathology was de-
tected.  
Pulmonary contusion, which usually results from blunt 
trauma, consists of hemorrhage into the alveolar and intersti-
tial spaces. Many contusions are small and contribute little 
to patient morbidity [6]. Treatment in such cases is usually 
supportive and patients heal without a sequel. Medical treat-
ment was not given to our case since pulmonary contusion 
was very confined. Follow-up with arterial blood gas analy-
sis and chest radiographs was sufficient and the patient im-
proved clinically and radiologically in early stages.  
Treatment  of  WD  is  lifelong  and  even  a  short-term, 
temporary break in pharmacologic therapy could result in 
copper accumulation. Therefore medical treatment should 
be reinstated as soon as possible postoperatively. Hence, we 
re-started medical treatment with his previous medications 
as soon as we ensured that oral intake would not cause a 
problem. 
In  conclusion,  general  anesthesia  can  be  successfully 
achieved in an asymptomatic, pediatric case of WD using 
agents that are least toxic to the liver. Preventive measures 
and meticulous observation and follow-up in the periopera-
tive and postoperative periods would minimize the compli-
cation rates and secure a successful outcome in WD cases.
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